Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | Palbociclib | 0.1 | uM | 3 | 625.00 | 556.96 | 872.00 | 1123.25 | 0.7763 | 0.5573 |
| SK-BR-3 | Omipalisib | 0.031623 | uM | 3 | 625.00 | 556.96 | 601.00 | 1123.25 | 0.5351 | 0.0781 |
| SK-BR-3 | Taxol | 0.0031623 | uM | 3 | 625.00 | 556.96 | 928.00 | 1123.25 | 0.8262 | 0.6561 |
| SK-BR-3 | Methotrexate | 3.1623 | uM | 3 | 625.00 | 556.96 | 1223.00 | 1123.25 | 1.0888 | 1.1754 |
| SK-BR-3 | Omipalisib | 0.01 | uM | 3 | 625.00 | 556.96 | 704.00 | 1123.25 | 0.6268 | 0.2605 |
| SK-BR-3 | Taxol | 0.031623 | uM | 3 | 625.00 | 556.96 | 612.00 | 1123.25 | 0.5449 | 0.0976 |
| SK-BR-3 | Omipalisib | 0.31623 | uM | 3 | 625.00 | 556.96 | 470.00 | 1123.25 | 0.4184 | -0.1544 |
| SK-BR-3 | 0 | uM | 3 | 625.00 | 556.96 | 1242.00 | 1123.25 | 1.1057 | 1.2088 | |
| SK-BR-3 | Palbociclib | 0.031623 | uM | 3 | 625.00 | 556.96 | 1072.00 | 1123.25 | 0.9544 | 0.9098 |
| SK-BR-3 | Taxol | 1 | uM | 3 | 625.00 | 556.96 | 397.00 | 1123.25 | 0.3534 | -0.2843 |
| SK-BR-3 | Palbociclib | 3.1623 | uM | 3 | 625.00 | 556.96 | 674.00 | 1123.25 | 0.6000 | 0.2074 |
| SK-BR-3 | Omipalisib | 0.0033113 | uM | 3 | 625.00 | 556.96 | 796.00 | 1123.25 | 0.7087 | 0.4231 |
| SK-BR-3 | Methotrexate | 0.1 | uM | 3 | 625.00 | 556.96 | 1015.00 | 1123.25 | 0.9036 | 0.8094 |
| SK-BR-3 | Omipalisib | 10 | uM | 3 | 625.00 | 556.96 | 328.00 | 1123.25 | 0.2920 | -0.4074 |
| SK-BR-3 | Methotrexate | 1 | uM | 3 | 625.00 | 556.96 | 940.00 | 1123.25 | 0.8369 | 0.6773 |
| SK-BR-3 | Methotrexate | 0.0033113 | uM | 3 | 625.00 | 556.96 | 997.00 | 1123.25 | 0.8876 | 0.7777 |
| SK-BR-3 | 0 | uM | 3 | 625.00 | 556.96 | 1089.00 | 1123.25 | 0.9695 | 0.9397 | |
| SK-BR-3 | 0 | uM | 3 | 625.00 | 556.96 | 986.00 | 1123.25 | 0.8778 | 0.7583 | |
| SK-BR-3 | 0 | uM | 3 | 625.00 | 556.96 | 746.00 | 1123.25 | 0.6641 | 0.3348 | |
| SK-BR-3 | 0 | uM | 3 | 625.00 | 556.96 | 1153.00 | 1123.25 | 1.0265 | 1.0523 | |
| SK-BR-3 | Taxol | 0.01 | uM | 3 | 625.00 | 556.96 | 426.00 | 1123.25 | 0.3793 | -0.2327 |
| SK-BR-3 | Taxol | 0.1 | uM | 3 | 625.00 | 556.96 | 422.00 | 1123.25 | 0.3757 | -0.2398 |
| SK-BR-3 | Methotrexate | 0.31623 | uM | 3 | 625.00 | 556.96 | 1268.00 | 1123.25 | 1.1289 | 1.2545 |
| SK-BR-3 | Taxol | 0.00016596 | uM | 3 | 625.00 | 556.96 | 1275.00 | 1123.25 | 1.1351 | 1.2668 |
| SK-BR-3 | Palbociclib | 19.9526 | uM | 3 | 625.00 | 556.96 | 692.00 | 1123.25 | 0.6161 | 0.2393 |